| 產(chǎn)品名稱 | Cannabidiol - CBD |
| 產(chǎn)品貨號(hào) | Axon 1234 CAS [13956-29-1] MF C21H30O2MW 314.46 Purity: 97% Soluble in DMSO Description Cannabidiol does not bind to CB1 or CB2 receptors but it does block the effects of cannabinoid agonists by an unknown indirect way. Recently it was found to be an antagonist at the putative new cannabinoid receptor, GPR55, a GPCR expressed in the caudate nucleus and putamen; a promising therapeutic agent for the treatment of psychosis, hyperalgesia, seizures, and stroke References Certificates Categories Extra info A Thomas et al. Cannabidiol displays unexpectedly high potency as an antagonist of CB1?and CB2?receptor agonists in vitro.?Br. J. Pharmacol. 2007,150 (5), 613–23.? ? E Ryberg et al. The orphan receptor GPR55 is a novel cannabinoid receptor. Br. J. Pharmacol. 2007, 152, 1092–1101. ? LE Long et al. The pharmacological actions of cannabidiol. Drugs Fut. 2005, 30(7), 747-753. Certificate of Analysis Material Safety Data Sheet CNS Pain & Inflammation GPR55 A15 GPR55 antagonist Chemical name 2-((1R,6R)-6-Isopropenyl-3-methyl-cyclohex-2-enyl)-5-pentyl-benzene-1,3-diol Parent CAS No. [13956-29-1] Order Size Unit Price Stock 10 mg €105.00 In Stock |
| 產(chǎn)品價(jià)格 | 現(xiàn)貨詢價(jià)，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
Cannabidiol - CBDAxon 1234 CAS [13956-29-1] MF C21H30O2
Description
Cannabidiol does not bind to CB1 or CB2 receptors but it does block the effects of cannabinoid agonists by an unknown indirect way. Recently it was found to be an antagonist at the putative new cannabinoid receptor, GPR55, a GPCR expressed in the caudate nucleus and putamen; a promising therapeutic agent for the treatment of psychosis, hyperalgesia, seizures, and stroke
GPR55 antagonist
Chemical name2-((1R,6R)-6-Isopropenyl-3-methyl-cyclohex-2-enyl)-5-pentyl-benzene-1,3-diol Parent CAS No.[13956-29-1] |
| 產(chǎn)品資料 |
